Skip to content

Clinical trials

Phase 2 Small Cell Lung Carcinoma trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 2 Country / region: Belgium Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20111
20131
20143
20151
20213
20221
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated4
Active, not recruiting2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
AbbVie1
Bayer1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Celgene1
EMD Serono Research & Development Institute, Inc.1
ETOP IBCSG Partners Foundation1
European Lung Cancer Working Party1
Exelixis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma17
Carcinoma, Non-Small-Cell Lung3
Melanoma3
Breast Neoplasms2
Carcinoma, Hepatocellular2
Anus Neoplasms1
Brain Neoplasms1
Carcinoma, Merkel Cell1
Carcinoma, Renal Cell1
Carcinoma, Small Cell1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.